Virtu Financial’s BiomX PHGE Stock Holding History

Virtu Financial’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-284	Closed	-$19K	–	1747
2023 Q2	$19K	Buy	+284	New	+$16.5K	﹤0.01%	1270
2022 Q4	–	Sell	-362	Closed	-$23K	–	2022
2022 Q3	$23K	Buy	+362	New	+$46.1K	﹤0.01%	1367

Other funds holding PHGE

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's PHGE Position: Q3 2023 in Review

Virtu Financial sold out of BiomX (PHGE) in Q3 2023, closing a stake of 284 shares — an estimated $19K sold.

Virtu Financial first reported a position in PHGE in Q3 2022 and held it in 2 quarters. The position peaked at $23K in Q3 2022. 10 funds tracked by Wall St. Rank hold PHGE as of Q3 2023.

Virtu Financial reported no remaining BiomX position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 284 BiomX shares in Q3 2023, an estimated $19K.
Virtu Financial first reported a position in BiomX in Q3 2022 and held it in 2 quarters.
Virtu Financial's BiomX position peaked at $23K in Q3 2022.
10 funds tracked by Wall St. Rank held BiomX as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.